Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
AbbVie NYSE:ABBV |
365,59 B | 2,49% | 4/6 | 25,40% | -29,65% | 20,95% | DOWN |
|
Amgen NasdaqGS:AMGN |
184,67 B | 7,37% | 3/6 | 2,72% | -4,64% | 2,17% | UP |
|
Gilead Sciences NasdaqGS:GILD |
173,93 B | 3,30% | 5/6 | 4,53% | -57,56% | 14,18% | UP |
|
Alnylam Pharmaceuticals NasdaqGS:ALNY |
43,81 B | 46,06% | 4/6 | 49,91% | 4,84% | 36,22% | DOWN |
|
Alexion Pharmaceuticals NasdaqGM:ALXN |
40,34 B | 0,00% | 4/4 | 0,00% | 0,00% | -100,00% | UP |
|
Biogen NasdaqGS:BIIB |
25,29 B | -10,57% | 1/6 | -1,25% | 8,95% | 18,08% | UP |
|
Incyte NasdaqGS:INCY |
18,88 B | 41,79% | 5/6 | 8,74% | 28,77% | 12,27% | UP |
|
BioMarin Pharmaceutical NasdaqGS:BMRN |
10,81 B | 12,22% | 5/6 | 45,50% | 59,05% | 67,23% | DOWN |
|
Arrowhead Pharmaceuticals NasdaqGS:ARWR |
8,56 B | 48,13% | 5/6 | -45,97% | 18,92% | 30,89% | UP |
|
Blueprint Medicines NasdaqGS:BPMC |
8,38 B | 45,26% | 4/6 | 42,18% | -48,48% | 0,64% | UP |
|
Cidara Therapeutics NasdaqCM:CDTX |
6,97 B | -59,17% | 2/6 | 0,00% | -652349,57% | -100,00% | UP |
|
Arena Pharmaceuticals NasdaqGM:ARNA |
6,17 B | 0,00% | 0,00% | 0,00% | 0,00% | UP | |
|
Amicus Therapeutics NasdaqGM:FOLD |
4,54 B | 19,97% | 5/6 | 59,76% | -47,65% | 0,35% | UP |
|
Viking Therapeutics NasdaqCM:VKTX |
3,93 B | 0,00% | 0/4 | 0,00% | 0,00% | 193,25% | UP |
|
ACADIA Pharmaceuticals NasdaqGS:ACAD |
3,81 B | 29,02% | 5/6 | 15,27% | -26,50% | 45,61% | DOWN |
|
ChemoCentryx NasdaqGS:CCXI |
3,74 B | 0,00% | 0/4 | 0,00% | 0,00% | -100,00% | UP |
|
CymaBay Therapeutics NasdaqGS:CBAY |
3,72 B | 0,00% | 1/4 | 0,00% | 0,00% | -100,00% | UP |
|
Catalyst Pharmaceuticals NasdaqCM:CPRX |
3,05 B | 40,93% | 5/6 | 5,58% | 23,19% | 40,11% | UP |
|
Travere Therapeutics NasdaqGM:TVTX |
2,94 B | 10,07% | 5/6 | 42,67% | -58,82% | 31,95% | UP |
|
BioCryst Pharmaceuticals NasdaqGS:BCRX |
2,41 B | 110,83% | 5/6 | -11,42% | 26,44% | 108,55% | UP |
